<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/527BA76D-A411-4C51-A7A2-A0B4DBB3A352"><gtr:id>527BA76D-A411-4C51-A7A2-A0B4DBB3A352</gtr:id><gtr:firstName>Janet</gtr:firstName><gtr:surname>Fraser</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8087A3C3-09A8-4495-8205-03AF95BFFB0E"><gtr:id>8087A3C3-09A8-4495-8205-03AF95BFFB0E</gtr:id><gtr:firstName>Jean</gtr:firstName><gtr:surname>Manson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/59C935DB-ED75-4E97-B16D-736F9EC8B96E"><gtr:id>59C935DB-ED75-4E97-B16D-736F9EC8B96E</gtr:id><gtr:firstName>Moira</gtr:firstName><gtr:surname>Bruce</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9721848"><gtr:id>17B70501-B6B3-47A7-A995-D38D19037073</gtr:id><gtr:title>Understanding the key events of TSE susceptibility and pathogenesis as a basis for disease intervention</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9721848</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3595843</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public lecture on Prion Diseases</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>358960AC-4590-4B4B-B34F-22A73ECE38A1</gtr:id><gtr:impact>Public lecture to inform on the current situation on vCJD</gtr:impact><gtr:outcomeId>56c1f8f3b314b2.84079809</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical Detective Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>89AE331B-4D9B-4D64-9502-77341C28F94B</gtr:id><gtr:impact>100 members of the public attended this public lecture and participated in the discussion afterwards

There have been emails from attendees requesting further information and a student has requested a placement.</gtr:impact><gtr:outcomeId>ShRvSZhpyCA</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Prion 2016 chair and invited speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>45740B18-E2DC-41E4-B594-D3BC33B28507</gtr:id><gtr:impact>invited talk to international meeting</gtr:impact><gtr:outcomeId>58bd4b2822fce3.86560366</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the International Science Advisory Council of APRI</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6BF216C6-A0EF-4930-B92A-10DC961D9DE3</gtr:id><gtr:impact>The importance of this committee which I now chair is to provide scientific knowledge and expertise to the growing scientific community of the APRI</gtr:impact><gtr:outcomeId>ZWNVcPTjyBh</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the ACDP</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>36A02B93-6CC0-4014-9F01-D70E05D8A4B5</gtr:id><gtr:impact>The Advisory Committee on Dangerous pathogens advises the UK government on all issues related to dangerous pathogens from situations, in the field, in health care and laboratory practice. I serve on the committee as the expert on the Transmissible Spongiform Encephalopathies</gtr:impact><gtr:outcomeId>bvz7Yv6fNjU</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the CJD Sample Oversight Committee Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5878DD26-B90A-4D7E-8CC2-40582CA6BE56</gtr:id><gtr:impact>The committee aims to facilitate the development of diagnostics for vCJD through working with developers and providing access to rare samples</gtr:impact><gtr:outcomeId>rkpScXXqDHh</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the British Neuroscience Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>356C165B-E6C4-4A3E-B0EC-E9B5569536AC</gtr:id><gtr:outcomeId>pz9cTFBTzRy</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the UK SEAC Advisory Body</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD087C57-5DE2-4E79-8634-3E20824CA7DC</gtr:id><gtr:impact>Spongiform Encephalopathy Advisory Committee advised Government on all accept of the Transmissible Spongiform Encephalopathies throughout the BSE and vCJD epidemics</gtr:impact><gtr:outcomeId>RriG7TJeFFs</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO TSE Working Group</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>26042395-0D63-4F6D-A280-933AB3734388</gtr:id><gtr:impact>developed policy on prion diseases</gtr:impact><gtr:outcomeId>qwPK2twTjcL</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the European Food Safety Authority</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F5BE5BFF-4C29-4F59-8B26-180E87A46C8B</gtr:id><gtr:impact>involved in development of policy on prion diseases</gtr:impact><gtr:outcomeId>tLEj8xgWTLE</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>38E33C9B-C92A-4B8E-9205-30BF26611519</gtr:id><gtr:title>In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>56c1fc796bdd19.62095680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>665EC0D4-DB37-43CD-A328-EE2F1F475C4F</gtr:id><gtr:title>Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>kDZDMsoNknm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>668620B5-4E7D-4936-9D19-6982F2BCDE1F</gtr:id><gtr:title>The role of host PrP in Transmissible Spongiform Encephalopathies.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26e30d35a7c5d36181d91a4831096629"><gtr:id>26e30d35a7c5d36181d91a4831096629</gtr:id><gtr:otherNames>Cancellotti E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56c1fc7a7d3a71.25377025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCED85EB-8739-4D3D-9C48-D709FEB19D3B</gtr:id><gtr:title>Isolated lymphoid follicle maturation induces the development of follicular dendritic cells.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e3ed7428acbeac9821690a784d0feaa"><gtr:id>2e3ed7428acbeac9821690a784d0feaa</gtr:id><gtr:otherNames>Glaysher BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>06C935FC0B9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDDC2FAD-51ED-4E1E-B86E-8CFC4138E9C7</gtr:id><gtr:title>Insights into Mechanisms of Chronic Neurodegeneration.</gtr:title><gtr:parentPublicationTitle>International journal of molecular sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06d2584ebbcc5853cd21c01b4c7378c8"><gtr:id>06d2584ebbcc5853cd21c01b4c7378c8</gtr:id><gtr:otherNames>Diack AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1422-0067</gtr:issn><gtr:outcomeId>56c1fc73ae8e24.18208766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44078DB1-8A20-49C7-8D97-3527E330D3FC</gtr:id><gtr:title>Variant CJD. 18 years of research and surveillance.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06d2584ebbcc5853cd21c01b4c7378c8"><gtr:id>06d2584ebbcc5853cd21c01b4c7378c8</gtr:id><gtr:otherNames>Diack AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>5675dda154528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97B11D90-29F8-4488-AC10-710F9A09C042</gtr:id><gtr:title>Predicting susceptibility and incubation time of human-to-human transmission of vCJD.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56c1fc7b107e06.85567810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C4CB0EB-071C-413D-97E5-AC924326386A</gtr:id><gtr:title>Role of the draining lymph node in scrapie agent transmission from the skin.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e3ed7428acbeac9821690a784d0feaa"><gtr:id>2e3ed7428acbeac9821690a784d0feaa</gtr:id><gtr:otherNames>Glaysher BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn><gtr:outcomeId>E407D07A6AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCEDF38F-397B-4726-A170-8CA8C3A478FF</gtr:id><gtr:title>The transmissible spongiform encephalopathies: emerging and declining epidemics.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a59d8de7b221b486c1379d6e4f1b48"><gtr:id>35a59d8de7b221b486c1379d6e4f1b48</gtr:id><gtr:otherNames>Manson JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>56c1fc7ad1a9b2.29588971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E3CC5AA-3EB0-4015-944E-81C1F66877FE</gtr:id><gtr:title>Role of the GALT in scrapie agent neuroinvasion from the intestine.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e3ed7428acbeac9821690a784d0feaa"><gtr:id>2e3ed7428acbeac9821690a784d0feaa</gtr:id><gtr:otherNames>Glaysher BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>0B5FA56CABE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66E791AC-0A3F-4C7F-88D7-68709210A475</gtr:id><gtr:title>No major change in vCJD agent strain after secondary transmission via blood transfusion.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>WoXTwiZT4dR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AB24C06-DF3E-4602-B0D5-D0D28FA349D4</gtr:id><gtr:title>The effects of host age on the transport of complement-bound complexes to the spleen and the pathogenesis of intravenous scrapie infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/700fbb235965330040dfaa9897517a46"><gtr:id>700fbb235965330040dfaa9897517a46</gtr:id><gtr:otherNames>Brown KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>skPktDbgQAL</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9721848</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>